Bajema Elizabeth A, Roberts Kaleigh F, Meade Thomas J
Met Ions Life Sci. 2019 Jan 14;19. doi: 10.1515/9783110527872-017.
The use of metals in medicine has grown impressively in recent years as a result of greatly advanced understanding of biologically active metal complexes and metal-containing proteins. One landmark in this area was the introduction of cisplatin and related derivatives as anticancer drugs. As the body of literature continues to expand, it is necessary to inspect sub-classes of this group with more acute detail. This chapter will review preclinical research of cobalt complexes coordinated by Schiff base ligands. Cobalt-Schiff base complexes have a wide variety of potential therapeutic functions, including as antimicrobials, anticancer agents, and inhibitors of protein aggregation. While providing a broad introduction to this class of agents, this chapter will pay particular attention to agents for which mechanisms of actions have been studied. Appropriate methods to assess activity of these complexes will be reviewed, and promising preclinical complexes in each of the following therapeutic areas will be highlighted: antimicrobial, antiviral, cancer therapy, and Alzheimer's disease.
近年来,随着对生物活性金属配合物和含金属蛋白质的认识有了极大的进步,金属在医学中的应用显著增加。这一领域的一个里程碑是顺铂及其相关衍生物作为抗癌药物的引入。随着文献数量的不断增加,有必要更细致地审视这一类别的子类。本章将回顾由席夫碱配体配位的钴配合物的临床前研究。钴-席夫碱配合物具有多种潜在的治疗功能,包括作为抗菌剂、抗癌剂和蛋白质聚集抑制剂。在对这类药物进行广泛介绍的同时,本章将特别关注已研究其作用机制的药物。将回顾评估这些配合物活性的适当方法,并突出以下每个治疗领域中有前景的临床前配合物:抗菌、抗病毒、癌症治疗和阿尔茨海默病。